JP4264322B2 - Preparation method of dermal papilla cell preparation - Google Patents
Preparation method of dermal papilla cell preparation Download PDFInfo
- Publication number
- JP4264322B2 JP4264322B2 JP2003346937A JP2003346937A JP4264322B2 JP 4264322 B2 JP4264322 B2 JP 4264322B2 JP 2003346937 A JP2003346937 A JP 2003346937A JP 2003346937 A JP2003346937 A JP 2003346937A JP 4264322 B2 JP4264322 B2 JP 4264322B2
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell
- preparation
- hair
- dermal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002360 preparation method Methods 0.000 title claims description 39
- 230000002500 effect on skin Effects 0.000 title claims description 24
- 210000004027 cell Anatomy 0.000 claims description 110
- 238000000034 method Methods 0.000 claims description 37
- 239000006285 cell suspension Substances 0.000 claims description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- 238000005138 cryopreservation Methods 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 102000008186 Collagen Human genes 0.000 claims description 3
- 108010035532 Collagen Proteins 0.000 claims description 3
- 241000282414 Homo sapiens Species 0.000 claims description 3
- 229920001436 collagen Polymers 0.000 claims description 3
- 210000000185 follicular epithelial cell Anatomy 0.000 claims description 2
- 210000003780 hair follicle Anatomy 0.000 description 33
- 210000002919 epithelial cell Anatomy 0.000 description 32
- 210000004209 hair Anatomy 0.000 description 20
- 241000699666 Mus <mouse, genus> Species 0.000 description 19
- 210000003491 skin Anatomy 0.000 description 14
- 210000002615 epidermis Anatomy 0.000 description 13
- 210000004927 skin cell Anatomy 0.000 description 13
- 238000002054 transplantation Methods 0.000 description 13
- 210000001519 tissue Anatomy 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- 210000000130 stem cell Anatomy 0.000 description 9
- 108700012813 7-aminoactinomycin D Proteins 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- 210000004207 dermis Anatomy 0.000 description 8
- YXHLJMWYDTXDHS-IRFLANFNSA-N 7-aminoactinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=C(N)C=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 YXHLJMWYDTXDHS-IRFLANFNSA-N 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 7
- 238000007710 freezing Methods 0.000 description 7
- 230000008014 freezing Effects 0.000 description 7
- 239000002953 phosphate buffered saline Substances 0.000 description 7
- 238000011830 transgenic mouse model Methods 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000003661 hair follicle regeneration Effects 0.000 description 6
- 102000004142 Trypsin Human genes 0.000 description 5
- 108090000631 Trypsin Proteins 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000012588 trypsin Substances 0.000 description 5
- 102000029816 Collagenase Human genes 0.000 description 4
- 108060005980 Collagenase Proteins 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 4
- 241000699660 Mus musculus Species 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 210000003850 cellular structure Anatomy 0.000 description 4
- 229960002424 collagenase Drugs 0.000 description 4
- 238000000684 flow cytometry Methods 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 238000010257 thawing Methods 0.000 description 4
- 238000011316 allogeneic transplantation Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000008150 cryoprotective solution Substances 0.000 description 3
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 3
- 230000003779 hair growth Effects 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 241000282412 Homo Species 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000011580 nude mouse model Methods 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000012089 stop solution Substances 0.000 description 2
- 238000002689 xenotransplantation Methods 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 102000005598 Chondroitin Sulfate Proteoglycans Human genes 0.000 description 1
- 108010059480 Chondroitin Sulfate Proteoglycans Proteins 0.000 description 1
- 101000994365 Homo sapiens Integrin alpha-6 Proteins 0.000 description 1
- 102100032816 Integrin alpha-6 Human genes 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000002577 cryoprotective agent Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000000442 hair follicle cell Anatomy 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229920005644 polyethylene terephthalate glycol copolymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003761 preservation solution Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003168 reconstitution method Methods 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
本発明は活性毛乳頭細胞を含有し、且つ含有する上皮系細胞が不活化された毛乳頭細胞調製品を調製する方法を提供する。 The present invention provides a method for preparing a hair papilla cell preparation that contains active hair papilla cells and that contains the epithelial cells inactivated.
毛包は成熟した生体で自己再生をほぼ一生涯を通じて繰り返す例外的な器官である。その自己再生の仕組みを解明することは、組織や細胞移植による脱毛治療、毛包や皮脂腺を含有する自然に近い機能的にも優れた皮膚シートの構築など、ニーズの高い臨床応用に繋がるものと期待される。近年、幹細胞研究への関心の高まりと共に毛包上皮幹細胞(上皮細胞)の研究が急速に進展し、また毛包特異的な間葉系細胞たる毛乳頭細胞についてもその性質が少しずつ判ってきた。毛乳頭細胞は毛包の自己再生のために毛包上皮幹細胞に活性化シグナルを送るいわば司令塔の役割を担い、毛包再構成評価系においては毛包上皮幹細胞と共に欠くことのできない細胞であることが判っている(Kishimoto et al., Proc. Natl. Acad. Sci. USA (1999), Vol.96, pp. 7336-7341;非特許文献1)。 The hair follicle is an exceptional organ that repeats self-renewal for almost a lifetime in a mature organism. Elucidating the mechanism of self-regeneration will lead to clinical applications with high needs such as hair loss treatment by tissue and cell transplantation, construction of skin sheets that are functionally superior in nature containing hair follicles and sebaceous glands. Be expected. In recent years, research on hair follicle epithelial stem cells (epithelial cells) has progressed rapidly with increasing interest in stem cell research, and the properties of hair follicle papilla cells, which are hair follicle-specific mesenchymal cells, have gradually become known. . Papilla cells play the role of a control tower that sends activation signals to hair follicle epithelial stem cells for self-renewal of hair follicles, and are essential cells with hair follicle epithelial stem cells in the evaluation system for hair follicle reconstitution (Kishimoto et al., Proc. Natl. Acad. Sci. USA (1999), Vol. 96, pp. 7336-7341; Non-Patent Document 1).
毛包の再生を目指して、動物モデルでの毛包再構成実験がこれまで様々な方法で行われている。Weinberg et al., J. Invest. Dermatol. (1993), Vol.100, pp. 229-236(非特許文献2)には細胞移植法による毛包再構成方法が記載されている。Weinbergらの移植系は毛乳頭細胞、新生児上皮系細胞(毛包上皮幹細胞を含む)のほかにマウス3T3細胞が加えられた複雑な構成を有する。Weinbergらによれば上皮系細胞画分を移植系に加えなくても毛包が再生するとのことである。しかしながら、これは毛乳頭細胞から未分化上皮系細胞(毛包上皮幹細胞)や毛包原基を完全に除去することが困難なために起きた現象であると考えられる。その後、Kishimotoら(前掲)は体毛毛乳頭細胞の単離精製にはじめて成功し、単離精製した毛乳頭細胞を用い、動物モデルでの細胞移植法による毛包再構成実験を行った結果、毛乳頭細胞と上皮細胞との組み合わせを含む細胞画分を移植すると毛包が再構成され、発毛が認められるが、毛乳頭細胞又は上皮細胞のいずれかしか含まない細胞画分を移植した場合、発毛が認められないことを見出している。 Aiming at the regeneration of hair follicles, hair follicle reconstruction experiments using animal models have been conducted in various ways. Weinberg et al., J. Invest. Dermatol. (1993), Vol. 100, pp. 229-236 (Non-Patent Document 2) describes a method for reconstructing hair follicles by cell transplantation. The transplantation system of Weinberg et al. Has a complicated structure in which mouse 3T3 cells are added in addition to dermal papilla cells and neonatal epithelial cells (including hair follicle epithelial stem cells). According to Weinberg et al., The hair follicles regenerate without adding an epithelial cell fraction to the transplantation system. However, this is considered to be a phenomenon that occurs because it is difficult to completely remove undifferentiated epithelial cells (hair follicle epithelial stem cells) and hair follicle primordia from hair papilla cells. After that, Kishimoto et al. (Supra) succeeded in isolating and purifying hair follicle papillae cells for the first time. As a result of hair follicle reconstitution experiments using cell transplantation methods in animal models, When a cell fraction containing a combination of papillary cells and epithelial cells is transplanted, the hair follicle is reconstituted and hair growth is observed, but if a cell fraction containing only hair papillary cells or epithelial cells is transplanted, It has been found that no hair growth is observed.
しかしながら、Kishimotoらによる毛乳頭細胞の精製方法は、毛乳頭細胞がバーシカン(コンドロイチン硫酸プロテオグリカン類)を特異的に発現する性質を有することを利用し、バーシカン遺伝子にリポーター遺伝子を繋げたDNAを用いて作製したトランスジェニックマウスモデルによってバーシカン発現を指標とし、単離・濃縮を行うものである。従って、この方法はトランスジェニックマウスの作製、セルソーターによる毛乳頭細胞の純化を要する。特に、毛包再構成方法において毛包を実際に再生させ、発毛を起こさせるには大量の毛乳頭細胞が必要であり(例えば、1移植当たり500万個の細胞)、そのためこの方法では大量のトランスジェニックマウスの作製、長時間の高速セルソーターの使用を要し、経済的にも、また作業時間、労力の面においても問題があった。毛乳頭細胞の単離は例えばProuty et al., American J. Pathol. (1996) Vol.148, No.6, pp.1871-1885(非特許文献3)にも記載されているが、遠心分離により分画を繰り返す複雑で、純度が低く且つ収量の低い方法である。
本発明の課題は、トランスジェニックマウスを使用せず、簡単に、活性細胞成分として毛乳頭細胞のみを含有する毛乳頭細胞調製品を調製する方法を提供することにある。 An object of the present invention is to provide a method for easily preparing a hair papilla cell preparation containing only hair papilla cells as an active cell component without using a transgenic mouse.
本発明者は、驚くべきことに、皮膚組織から採取した真皮組織画分の細胞懸濁物を凍結保存すると、その懸濁物中に夾雑した毛包上皮細胞が特異的に死滅し、毛乳頭細胞は大半が活性であり続けることを見出した。その結果、活性細胞成分として毛乳頭細胞のみを含有する細胞調製品を得ることができた。 Surprisingly, the inventor of the present invention, when cryopreserving a cell suspension of a dermis tissue fraction collected from skin tissue, follicular epithelial cells contaminated in the suspension are specifically killed, and the hair papilla The cells were found to remain largely active. As a result, a cell preparation containing only hair papilla cells as active cell components could be obtained.
従って、本発明は毛乳頭細胞調製品を調製する方法であって、皮膚組織から表皮組織を取り除くことで得た真皮組織画分をコラーゲン処理して細胞懸濁物を調製し、次いで当該細胞懸濁物を凍結保存することで毛包上皮細胞を死滅させることを特徴とする方法を提供する。 Therefore, the present invention is a method for preparing a dermal papilla cell preparation, in which a dermal tissue fraction obtained by removing epidermal tissue from skin tissue is treated with collagen to prepare a cell suspension, and then the cell suspension is prepared. Provided is a method characterized in that hair follicle epithelial cells are killed by cryopreserving the suspension.
上記細胞懸濁物の細胞密度を1×105〜1×108/mlに調整してから凍結保存を行うことが好ましい。更に好ましくは、上記凍結保存は−80℃以下の温度で、例えば液体窒素の中で、好ましくは1週間以上の期間にわたって行う。 It is preferable to perform cryopreservation after adjusting the cell density of the cell suspension to 1 × 10 5 to 1 × 10 8 / ml. More preferably, the cryopreservation is performed at a temperature of −80 ° C. or lower, for example, in liquid nitrogen, preferably for a period of one week or longer.
好適な態様において、上記皮膚組織がマウス、ラット又はヒトに由来するものであってよい。 In a preferred embodiment, the skin tissue may be derived from a mouse, rat or human.
本発明により、トランスジェニックマウスを使用せず、簡単に、活性細胞成分として毛乳頭細胞のみを含有する毛乳頭細胞調製品を調製する方法を提供することができる。この毛乳頭細胞調製品は毛包再生のための移植手術や、毛包再構成の研究・開発に利用できる。特に、当該毛乳頭細胞調製品には活性上皮幹細胞の夾雑がないため、毛包の再生に使用する活性毛乳頭細胞と活性上皮毛幹細胞の細胞数の割合を精密に調整することが必要であり、しかも細胞を大量に必要とする場合、有利である。 According to the present invention, it is possible to provide a method for easily preparing a hair papilla cell preparation containing only hair papilla cells as active cell components without using a transgenic mouse. This dermal papilla cell preparation can be used for transplantation surgery for hair follicle regeneration and for research and development of hair follicle reconstruction. In particular, since the hair papilla cell preparation is free of active epithelial stem cells, it is necessary to precisely adjust the ratio of the number of active hair papilla cells and active epithelial hair stem cells used for hair follicle regeneration. This is advantageous when a large amount of cells are required.
本発明は毛乳頭細胞調製品を調製する方法を提供する。「毛乳頭細胞」とは、間葉系細胞として毛包最底部に位置し、毛包の自己再生のために毛包上皮幹細胞に活性化シグナルを送る、いわば司令塔の役割を担っている細胞をいう。本発明の方法は、皮膚組織から表皮組織を取り除くことで得た真皮組織画分をコラーゲン処理して細胞懸濁物を調製し、次いで当該細胞懸濁物を凍結保存することで毛包上皮細胞を死滅させることを特徴とする。 The present invention provides a method of preparing hair papilla cell preparations. “Papilla cells” are cells located at the bottom of the hair follicle as mesenchymal cells and send activation signals to the hair follicle epithelial stem cells for the self-renewal of hair follicles. Say. In the method of the present invention, a dermal tissue fraction obtained by removing epidermal tissue from skin tissue is subjected to collagen treatment to prepare a cell suspension, and then the cell suspension is cryopreserved to produce hair follicle epithelial cells. It is characterized by killing.
上記方法は、具体的には、例えば以下の通りにして実施できる。
1.哺乳動物の表皮を用意する。
2.この表皮を、必要ならタンパク質分解酵素溶液、例えばトリプシン溶液の中に適当な時間、例えば一晩静置し、その後表皮部分をピンセットなどで取り除き、残った真皮をコラゲナーゼで処理し、細胞懸濁液を調製する。
3.必要ならセルストレーナーにより懸濁液をろ過し、静置により沈殿物を除去する。
4.細胞数を計測し、適当な細胞密度、好ましくは1x105〜1x108/ml程度の細胞密度にて凍結保護液で再懸濁し、必要なら小分け分注し、通常の細胞保存方法に従い、凍結保存する。
5.適当な期間保存後、融解し、使用する。
Specifically, the above method can be performed, for example, as follows.
1. Prepare a mammalian epidermis.
2. If necessary, leave this epidermis in a proteolytic enzyme solution, such as a trypsin solution, for an appropriate time, for example overnight, then remove the epidermis with tweezers, treat the remaining dermis with collagenase, and To prepare.
3. If necessary, the suspension is filtered with a cell strainer, and the precipitate is removed by standing.
4). Count the number of cells, resuspend in a cryoprotective solution at an appropriate cell density, preferably about 1 × 10 5 to 1 × 10 8 / ml, aliquot if necessary, and cryopreserve according to normal cell storage methods To do.
5. After storage for an appropriate period, melt and use.
本発明において使用する哺乳動物の表皮はあらゆる哺乳動物に由来してよく、限定することなくマウス、ラット、モルモット、ウサギ、ヒトであってよい。動物の系統も限定されることはない。 The mammalian epidermis used in the present invention may be derived from any mammal, and may be a mouse, rat, guinea pig, rabbit, or human without limitation. The animal strain is not limited.
凍結方法は特に限定されることはないが、−20℃以下、好ましくは−50℃以下、より好ましくは−80℃以下の超低温冷凍庫中で、又は液体窒素中で保存する。凍結保存期間も特に限定されることがないが、上皮細胞が死滅するよう、例えば1日以上、好ましくは3日以上、より好ましくは1週間以上の期間とする。尚、液体窒素中で4ヶ月保存しても、毛乳頭細胞は生存し続けていることが確認された。
凍結保護液としては細胞の保存において使用されている通常の保存液、例えばセルバンカー2細胞凍結保存液(カタログNo.BLC−2)〔日本全業工業製〕が使用できる。
The freezing method is not particularly limited, but it is stored in an ultra-low temperature freezer at -20 ° C or lower, preferably -50 ° C or lower, more preferably -80 ° C or lower, or in liquid nitrogen. The cryopreservation period is not particularly limited, but is set to, for example, 1 day or longer, preferably 3 days or longer, more preferably 1 week or longer so that the epithelial cells are killed. It was confirmed that the dermal papilla cells continued to survive even after being stored in liquid nitrogen for 4 months.
As the cryoprotective solution, a conventional preservation solution used in cell preservation, for example, Cell
本発明の方法により調製した毛乳頭細胞調製品は上皮系細胞との組み合わせにおいて、毛包の再生のための移植に使用することができる。組み合わせは同種系でも、異種系でもよい。例えば、毛乳頭細胞調製品がマウスに由来する場合、上皮系細胞はマウスに由来するか(同種)、又はその他の種、例えばラット、ヒトに由来してもよい(異種)。また、この組み合わせをレシピエント動物に移植する場合、その移植は同種移植、即ち自己移植、同種同系移植もしくは同種異系移植であっても、異種移植であってもよい。同種移植の場合、毛乳頭細胞調製品及び上皮系細胞は共にレシピエントと同種である。異種移植では、毛乳頭細胞調製品又は上皮系細胞のいずれか一方がレシピエントと異種であり、他方がレシピエントと同種である場合と、双方がレシピエントと異種の場合がある。レシピエント動物としてはあらゆる哺乳動物、例えばヒト、マウス、ラットが挙げられる。 The dermal papilla cell preparation prepared by the method of the present invention can be used for transplantation for hair follicle regeneration in combination with epithelial cells. The combination may be the same or different. For example, when the dermal papilla cell preparation is derived from a mouse, the epithelial cells may be derived from a mouse (same species) or from other species such as rats, humans (heterologous). When this combination is transplanted into a recipient animal, the transplantation may be allotransplantation, that is, autotransplantation, allograft transplantation, allogeneic transplantation, or xenotransplantation. In the case of allogeneic transplantation, the dermal papilla cell preparation and epithelial cells are both allogeneic with the recipient. In xenotransplantation, either the dermal papilla cell preparation or the epithelial cells may be xenogeneic with the recipient and the other may be xenogeneic with the recipient, or both may be xenogeneic with the recipient. Recipient animals include all mammals such as humans, mice, and rats.
「上皮系細胞」は、皮膚の表皮または上皮の大部分を構成する細胞であり、真皮に接する1層の基底細胞から生じる。マウスを例にすると、上皮系細胞としては新生仔(もしくは胎児)に由来する上皮系細胞が好ましく使用できるが、ケラチノサイトの形態にある細胞の培養物であってもよい。このような細胞は、当業者周知の方法により所望のドナー動物の皮膚から調製することができる。 “Epithelial cells” are cells that make up the majority of the epidermis or epithelium of the skin and arise from a single layer of basal cells that touch the dermis. Taking mice as an example, epithelial cells derived from neonates (or fetuses) can be preferably used as epithelial cells, but a culture of cells in the form of keratinocytes may also be used. Such cells can be prepared from the skin of the desired donor animal by methods well known to those skilled in the art.
好適な態様において、上皮系細胞は以下のとおりにして調製できる。
1.哺乳動物の表皮を用意する。
2.この表皮を、必要なら0.25%トリプシン/PBS中で4℃下で一晩静置することでトリプシン処理する。
3.ピンセットなどにより表皮部分のみ剥離し、細切後、適当な培養液(例えばケラチノサイト用培養液)中で4℃で約1時間懸濁処理する。
4.この懸濁物を適当なポアサイズを持つセルストレーナーを通し、次いで遠心分離器にかけて上皮系細胞を回収する。
5.この細胞調製品はKGMあるいはSFM培地に所望の細胞密度で懸濁し、使用直前まで氷上に静置しておく。
In a preferred embodiment, epithelial cells can be prepared as follows.
1. Prepare a mammalian epidermis.
2. The epidermis is trypsinized by standing overnight at 4 ° C. in 0.25% trypsin / PBS if necessary.
3. Only the epidermis part is peeled off with tweezers, etc., and after chopping, suspended in an appropriate culture solution (for example, keratinocyte culture solution) at 4 ° C. for about 1 hour.
4). The suspension is passed through a cell strainer with an appropriate pore size and then centrifuged to collect epithelial cells.
5. This cell preparation is suspended in KGM or SFM medium at a desired cell density and left on ice until just before use.
以下に実施例を挙げて本発明をさらに詳細に説明する。
実験1
真皮細胞画分の凍結保存により、上皮細胞が死滅し、活性細胞として毛乳頭細胞のみを含有する細胞調製品が得られることを確認するため、バーシカン(Versican)プロモーター下流にマーカータンパク、LacZ、の構造遺伝子をつないだ発現ベクターを導入したトランスジェニックマウス(以下「バーシカン−LacZ TGマウス」)より採取した皮膚組織より得られた細胞画分を凍結保存し、融解した細胞調製品についてフローサイトメトリー解析した。
Hereinafter, the present invention will be described in more detail with reference to examples.
In order to confirm that cryopreservation of the dermal cell fraction kills epithelial cells and obtains a cell preparation containing only dermal papilla cells as active cells, the marker protein LacZ, downstream of the Versican promoter Flow cytometric analysis of cell preparations obtained by cryopreserving cell fractions obtained from skin tissue collected from transgenic mice (hereinafter referred to as “Versican-LacZ TG mice”) into which an expression vector linked with a structural gene has been introduced. did.
(1)バーシカン−LacZ TGマウスの真皮細胞からの「凍結保存」毛乳頭細胞調製品の調製
(1−1) バーシカン−LacZ TGマウスから生まれた新生仔(生後4日以内に使用)のうち、LacZ陽性の個体を選別した。バーシカン−LacZ TGマウスは、例えばKishimotoら(前掲)に記載の方法により作製することができる。
(1−2) 各個体をエタノールとリン酸緩衝生理食塩水(以下「PBS」)で洗浄後、背部皮膚を剥離し、0.25%トリプシン/PBS中で4℃下で一晩静置した。
(1−3) 翌日、ピンセットなどにより表皮と真皮を分離し、真皮側を0.35%コラゲナーゼ/DMEM(ダルベッコ変法イーグル最少培地。以下「DMEM」)により37℃下で約1時間ほど処理した。
(1−4) (1−3)の細胞を念入りに懸濁操作を行ったのち、70μメーターのポアサイズを持つセルストレーナーに通し、次いで遠心分離器(900g、10分)によって細胞を集めた。
(1−5) 細胞数を計測し、1x105〜 1x108/mlの細胞密度にて凍結保護液で再懸濁し、凍結チューブに分注、通常の細胞保存方法に従い、液体窒素内で保存した。
(1−6) 約1週間後に融解し、これを以下のフローサイトメトリー解析に用いた。
(1) Preparation of “cryopreserved” hair papilla cell preparation from dermal cells of Versican-LacZ TG mice (1-1) Among newborns born from Versican-LacZ TG mice (used within 4 days of birth) LacZ positive individuals were selected. Versican-LacZ TG mice can be prepared, for example, by the method described in Kishimoto et al.
(1-2) After washing each individual with ethanol and phosphate buffered saline (hereinafter “PBS”), the dorsal skin was peeled off and allowed to stand overnight at 4 ° C. in 0.25% trypsin / PBS. .
(1-3) The next day, the epidermis and dermis are separated with tweezers, etc., and the dermis side is treated with 0.35% collagenase / DMEM (Dulbecco's modified Eagle's minimal medium; hereinafter “DMEM”) at 37 ° C. for about 1 hour. did.
(1-4) After carefully suspending the cells of (1-3), the cells were passed through a cell strainer having a pore size of 70 μm, and then collected by a centrifuge (900 g, 10 minutes).
(1-5) The number of cells was counted, resuspended with a cryoprotectant at a cell density of 1 × 10 5 to 1 × 10 8 / ml, dispensed into a freezing tube, and stored in liquid nitrogen according to a normal cell storage method. .
(1-6) Thawed after about one week, and used for the following flow cytometry analysis.
(2)フルオロレポーター LacZフローサイトメトリー解析
実験材料
・フルオロレポーター LacZフローサイトメトリーキット(FluoroReporter lacZ flow cytometry kits) Molecular Probe社、カタログNo.F-1930(50反応分)/F-1931(250反応分)
・試薬の準備:
反応液:キット中のFDG試薬(Component A)をMiliQ水で1:10に希釈した。1サンプル当り50μLを使用した。
停止液:キット中のPI試薬(Component D)をキット付属の緩衝液で1:100に希釈した。1サンプル当り0.9mlを使用した。使用するまで氷中において4℃に冷やしておいた。染色媒体としては、上皮細胞を特異的に染色する特的抗体であるCD49fモノクローナル抗体(セロテック社製、MCA699)、死細胞を特異的に染色する7-ADD(ベックマンコールター、PN−1M3422)を用いた。
(2) Fluororeporter LacZ flow cytometry analysis materials / Fluororeporter LacZ flow cytometry kits Molecular Probe, Catalog No. F-1930 (50 reactions) / F-1931 (250 reactions)
・ Reagent preparation:
Reaction solution: FDG reagent (Component A) in the kit was diluted 1:10 with MiliQ water. 50 μL was used per sample.
Stop solution: The PI reagent (Component D) in the kit was diluted 1: 100 with the buffer supplied with the kit. 0.9 ml was used per sample. It was chilled to 4 ° C. in ice until use. As a staining medium, a CD49f monoclonal antibody (manufactured by Cellotech, MCA699), which is a specific antibody that specifically stains epithelial cells, and 7-ADD (Beckman Coulter, PN-1M3422) that specifically stains dead cells are used. It was.
(2−1) バーシカン−LacZ TGマウス由来の真皮細胞の懸濁液を〜1x107細胞数までの細胞数に調整して、750ulの染色媒体を加えて、1.5mlのエッペンチューブに移した。
(2−2) 3000回転で5分間遠心し、上澄みを捨てた。細胞ペレットを100μLの染色媒体に再懸濁した。この懸濁物を37℃の恒温槽で10分間プレインキュベーションした。
(2−3) 37℃の恒温槽で10分間プレインキュベーションしておいた反応液を50μL加えて、正確に1分間、37℃で反応を行った。
(2−4) 0.9ml の停止液を加え、氷中に保存した。
(2−5) 10分後に40μLの50mM PETG(正式名)(Component B)を加えて反応を完全に阻害した。
(2−6) すみやかにFACSで蛍光強度を測定した。フローサイトメーター(FACS)の操作方法はメーカーの取扱説明書によった。FACSの測定装置は例えば、ベックマン・コールター社のXL−MCLを用いることができる。本キットに使用されている蛍光色素Fluorescein(フルオロセイン)に適した検出設定で細胞の蛍光強度の分布を測定した。
(2-1) A suspension of dermal cells derived from versican-LacZ TG mice was adjusted to a cell number of up to ˜1 × 10 7 cells, 750 ul of staining medium was added, and the suspension was transferred to a 1.5 ml Eppendorf tube.
(2-2) The mixture was centrifuged at 3000 rpm for 5 minutes, and the supernatant was discarded. The cell pellet was resuspended in 100 μL staining media. This suspension was preincubated for 10 minutes in a 37 ° C. thermostat.
(2-3) 50 μL of a reaction solution preincubated for 10 minutes in a 37 ° C. constant temperature bath was added, and the reaction was performed at 37 ° C. for exactly 1 minute.
(2-4) 0.9 ml of stop solution was added and stored in ice.
(2-5) After 10 minutes, 40 μL of 50 mM PETG (official name) (Component B) was added to completely inhibit the reaction.
(2-6) The fluorescence intensity was immediately measured by FACS. The operation method of the flow cytometer (FACS) was according to the manufacturer's instruction manual. As the FACS measuring apparatus, for example, XL-MCL manufactured by Beckman Coulter can be used. The distribution of the fluorescence intensity of the cells was measured with a detection setting suitable for the fluorescent dye Fluorescein used in this kit.
(3)解析結果
Lac及び7-AADに基づくFACS解析は、凍結融解した細胞中のLacZ+細胞の大半が、凍結融解を経ても生細胞であることを示した(図1)。従って、毛乳頭細胞は凍結融解によって死滅しないこと明らかとなった。また、CD-49及び7-AADに基づくFACS解析では、CD-49+細胞(上皮系細胞)の大半が凍結融解後、7-AAD+画分(死画分)に存在することが示された(図2)。従って、凍結融解した細胞調製品中の生細胞はLacZ+、CD-49-、7-AAD-、即ち、毛乳頭細胞(LacZ+)且つ非上皮系細胞(CD-49-)であり、しかも生細胞(7-AAD-)である。以上の結果をまとめると、生細胞は大半が上皮系細胞ではなく、毛乳頭細胞であることが明らかとなった。よって、凍結融解により上皮系細胞を特異的に死滅させることができ、活性細胞として毛乳頭細胞のみ含む毛乳頭細胞調製品を調製できることが明らかとなった。
(3) Analysis results
FACS analysis based on Lac and 7-AAD showed that the majority of LacZ + cells in freeze-thawed cells were viable cells even after freezing and thawing (FIG. 1). Therefore, it became clear that the hair papilla cells were not killed by freezing and thawing. In addition, FACS analysis based on CD-49 and 7-AAD shows that most of CD-49 + cells (epithelial cells) are present in the 7-AAD + fraction (dead fraction) after freezing and thawing. (FIG. 2). Therefore, the living cells in the frozen and thawed cell preparation are LacZ + , CD-49 − , 7-AAD − , ie, hair papilla cells (LacZ + ) and non-epithelial cells (CD-49 − ), a - living cells (7-AAD). Summarizing the above results, it was found that most of the living cells were not epithelial cells but dermal papilla cells. Thus, it was revealed that epithelial cells can be specifically killed by freezing and thawing, and a hair papilla cell preparation containing only hair papilla cells as active cells can be prepared.
実験2
凍結融解毛乳頭細胞と上皮系細胞の混合移植により毛包再生を試みた。
I.各種細胞の調製
(1)マウス由来上皮細胞
(1−1) 手術前日、ICR系統マウスの新生仔より各個体をエタノールとリン酸緩衝生理食塩水(以下「PBS」)で洗浄後、背部皮膚を剥離し、0.25%トリプシン/PBS中で4℃下で一晩静置することで皮膚をトリプシン処理した。
(1−2) ピンセットなどにより表皮部分のみ剥離し、細切後、ケラチノサイト用培養液(以下「KGM」)中で4℃で約1時間懸濁処理した。
(1−3) セルストレーナーを通した(1−2)の懸濁物を遠心分離器(×900g、10分)にかけて上皮系細胞を回収した。
(1−4) レシピエント動物1個体あたり、2匹の新生仔由来に相当する量の上皮系細胞(細胞数として約1x107)を手術に用いた。相当量の細胞をKGMあるいはSFM培地で懸濁して、使用直前まで氷上に静置した。これを「マウス由来上皮細胞」調製品とする。
We tried to regenerate hair follicles by mixed transplantation of frozen and thawed dermal papilla cells and epithelial cells.
I. Preparation of various cells (1) Mouse-derived epithelial cells (1-1) The day before surgery, each individual was washed from a newborn ICR mouse with ethanol and phosphate buffered saline (hereinafter “PBS”), and the back skin was removed. The skin was trypsinized by exfoliation and standing overnight at 4 ° C. in 0.25% trypsin / PBS.
(1-2) Only the epidermis part was peeled off with tweezers, etc., and after chopping, suspended in a culture solution for keratinocytes (hereinafter “KGM”) at 4 ° C. for about 1 hour.
(1-3) The suspension of (1-2) that passed through a cell strainer was applied to a centrifuge (× 900 g, 10 minutes) to recover epithelial cells.
(1-4) For each recipient animal, an amount of epithelial cells (about 1 × 10 7 as the number of cells ) corresponding to two newborns was used in the operation. A considerable amount of cells were suspended in KGM or SFM medium and left on ice until just before use. This is a “mouse-derived epithelial cell” preparation.
(2)「用時調製」マウス由来真皮細胞調製品(比較例)の調製
(2−1) 手術前日、ICR系統マウスの新生仔より上記(1−1)、(1−2)と同様の方法により皮膚をトリプシン処理した。
(2−2) ピンセットにより表皮部分を剥離し、残った真皮を細切後、0.35%のコラゲナーゼを含んだ適当な培養液DMEM+10%FBS中で37℃で約1時間懸濁処理した。
(2−3) セルストレーナーを通した懸濁物(2−2)を遠心分離器にかけて真皮細胞を回収した。
(2−4)レシピエント動物1個体あたり、細胞数として約1x107の真皮細胞を手術に用いた。相当量の細胞をDMEM+10%FBSなどで懸濁して、使用直前まで氷上に静置した。これを「用時調製」マウス由来真皮細胞調製品とする。
(2) Preparation of “prepared in use” mouse-derived dermal cell preparation (comparative example) (2-1) Same day as above (1-1) and (1-2) from the day before surgery, from newborn ICR mouse strain The skin was trypsinized by the method.
(2-2) The epidermis part was peeled off with tweezers, and the remaining dermis was cut into small pieces and then suspended in an appropriate culture solution DMEM + 10% FBS containing 0.35% collagenase at 37 ° C. for about 1 hour.
(2-3) Dermal cells were collected by centrifuging the suspension (2-2) passed through the cell strainer.
(2-4) About 1 × 10 7 dermal cells were used for surgery per recipient animal. A considerable amount of cells were suspended in DMEM + 10% FBS or the like and left on ice until just before use. This is a “prepared at the time of use” mouse-derived dermal cell preparation.
(3)毛乳頭細胞画分を含む「凍結保存」マウス由来真皮細胞調製品の調製
(3−1) 新生仔ICR系統マウス背部皮膚を剥離し、表皮を採取した。
(3−2) トリプシン溶液で一晩静置し、翌日表皮をピンセットで取り除き、残った真皮をコラゲナーゼで処理、細胞懸濁液を調製した。
(3−3) セルストレーナーにより上記懸濁物をろ過し、そして静置により沈殿物を除去した。
(3−4) 細胞数を計測し、1x105〜 1x108/mlの細胞密度に凍結保護液で再懸濁し、凍結チューブに分注、通常の細胞保存方法に従い、液体窒素内で保存した。
(3−5) 約1週間後に融解し、移植実験に1x107個/移植を用いた。これを「凍結保存」マウス由来真皮細胞調製品とする。
(3) Preparation of “cryopreserved” mouse-derived dermis cell preparation containing hair follicle cell fraction (3-1) Newborn ICR strain mouse dorsal skin was peeled and epidermis was collected.
(3-2) The plate was allowed to stand overnight in a trypsin solution, and the epidermis was removed with tweezers the next day, and the remaining dermis was treated with collagenase to prepare a cell suspension.
(3-3) The suspension was filtered with a cell strainer, and the precipitate was removed by standing.
(3-4) The number of cells was counted, resuspended in a cryoprotective solution at a cell density of 1 × 10 5 to 1 × 10 8 / ml, dispensed into a freezing tube, and stored in liquid nitrogen according to a normal cell storage method.
(3-5) Thawed after about 1 week, and 1 × 10 7 cells / transplant were used for transplantation experiments. This is a “cryopreserved” mouse-derived dermal cell preparation.
II.毛包再構成方法(動物への移植方法)
上記マウス由来上皮細胞調製品(1−4)を「用時調製」マウス由来真皮細胞調製品(2−4)又は「凍結保存」マウス由来真皮細胞調製品(3−5)と混合した。これらの混合物を以下の「再構成毛包作成手順」の「細胞懸濁液」として用いた。
II. Hair follicle reconstruction method (implantation method to animals)
The mouse-derived epithelial cell preparation (1-4) was mixed with “prepared when used” mouse-derived dermal cell preparation (2-4) or “cryopreserved” mouse-derived dermal cell preparation (3-5). These mixtures were used as “cell suspension” in the following “reconstruction hair follicle preparation procedure”.
<再構成毛包作成手順>
用意するもの:
レシピエント動物(Balb−c nu/nn系統ヌードマウス。5週齢以上)、
シリコーン製の直径1センチ程度のドーム状キャップ(以下バルブと呼称)、
麻酔薬、
手術用ハサミ、ピンセット、縫合器、
マイクロピペッター
細胞懸濁液(培養液DMEM+10%FBS約150μlに懸濁)
<Reconstruction hair follicle creation procedure>
Things to prepare:
Recipient animal (Balb-c nu / nn strain nude mouse, 5 weeks of age or older),
Silicone dome-shaped cap with a diameter of about 1 cm (hereinafter referred to as “bulb”),
Anesthetic,
Surgical scissors, tweezers, suture device,
Micropipetter Cell suspension (suspended in about 150 μl of culture medium DMEM + 10% FBS)
<手順>
(i) ヌードマウスを麻酔した。
(ii) 背部皮膚を直径1センチ弱に切り取った。
(iii)傷口にバルブを挿入し、縫合器で固定した。
(iv) バルブ内に、細胞懸濁液をピペッターを用いて注入した。
(v) そのまま約1週間飼育し、バルブをはずした。
(vi) バルブをはずした後、1〜6週間後(通常は2週間後)、かさぶたが取れた跡に、再構成毛包の生育を観察した。
<Procedure>
(I) Nude mice were anesthetized.
(Ii) The back skin was cut to a diameter of less than 1 cm.
(Iii) A valve was inserted into the wound and fixed with a suture instrument.
(Iv) The cell suspension was injected into the valve using a pipettor.
(V) They were kept for about a week and the valve was removed.
(Vi) After removing the bulb, the growth of the reconstructed hair follicle was observed after 1-6 weeks (usually after 2 weeks), after the scab was removed.
毛包再構成実験の結果を以下の表及び図3に示す。「用時調製」マウス由来真皮細胞調製品のみを移植した場合でも毛包再生が認められるのに対し、「凍結保存」マウス由来真皮細胞調製品のみを移植した場合には毛包再生は認められなかった。この結果は、Kishimotoら(前掲)のトランスジェニックマウス由来の真皮細胞画分からセルソーターにより純化した毛乳頭細胞を用いて得られた結果と一致し、「凍結保存」マウス由来真皮細胞調製品には活性細胞成分として毛乳頭細胞のみが含まれていることを実証した。
本発明により調製された毛乳頭調製品は毛包再構成についての研究・開発に利用されるの再生のための移植に利用できる。 The dermal papilla preparation prepared according to the present invention can be used for transplantation for regeneration, which is used for research and development of hair follicle reconstitution.
Claims (8)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003346937A JP4264322B2 (en) | 2003-10-06 | 2003-10-06 | Preparation method of dermal papilla cell preparation |
KR1020067008767A KR101082621B1 (en) | 2003-10-06 | 2004-09-30 | Method of preparing hair papilla cell preparation |
CN2004800291374A CN1863907B (en) | 2003-10-06 | 2004-09-30 | Method of preparing hair papilla cell preparation, composition and method for regenerating hair follicle and animal having regenerated hair follicle |
KR1020117016054A KR101156797B1 (en) | 2003-10-06 | 2004-09-30 | Animal having regenerated hair follicle |
US10/574,697 US7718426B2 (en) | 2003-10-06 | 2004-09-30 | Preparation method of a hair dermal papilla cell preparation, composition and method for regenerating hair follicles, and animal having regenerated hair follicles |
KR1020117016056A KR101156868B1 (en) | 2003-10-06 | 2004-09-30 | Composition for regenerating hair follicle |
EP04788471.3A EP1688484B1 (en) | 2003-10-06 | 2004-09-30 | Method of preparing hair papilla cell preparation, composition and method for regenerating hair follicle and animal having regenerated hair follicle |
PCT/JP2004/014779 WO2005033302A1 (en) | 2003-10-06 | 2004-09-30 | Method of preparing hair papilla cell preparation, composition and method for regenerating hair follicle and animal having regenerated hair follicle |
TW093130247A TWI346697B (en) | 2003-10-06 | 2004-10-06 | Method for preparing papilla cells-containing preparation |
TW100108596A TWI502069B (en) | 2003-10-06 | 2004-10-06 | Three-dimensional skin equivalent |
US12/782,284 US20100227397A1 (en) | 2003-10-06 | 2010-05-18 | Preparation method of a hair dermal papilla cell preparation, composition and method for regenerating hair follicles, and animal having regenerated hair follicles |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003346937A JP4264322B2 (en) | 2003-10-06 | 2003-10-06 | Preparation method of dermal papilla cell preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005110540A JP2005110540A (en) | 2005-04-28 |
JP4264322B2 true JP4264322B2 (en) | 2009-05-13 |
Family
ID=34539696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003346937A Expired - Lifetime JP4264322B2 (en) | 2003-10-06 | 2003-10-06 | Preparation method of dermal papilla cell preparation |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP4264322B2 (en) |
CN (1) | CN1863907B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200731982A (en) * | 2005-10-17 | 2007-09-01 | Aderans Res Inst Inc | Method of delivering cells to the skin |
JP5258213B2 (en) * | 2006-06-27 | 2013-08-07 | 株式会社 資生堂 | Cell mass that can form primitive organs composed of multiple cell types derived from somatic |
JP5164439B2 (en) * | 2007-06-12 | 2013-03-21 | 株式会社 資生堂 | Hair papilla cell culture method |
CN101775366A (en) * | 2010-02-05 | 2010-07-14 | 中国人民解放军第四军医大学 | Preparation method of tissue engineering skin containing hair follicles |
-
2003
- 2003-10-06 JP JP2003346937A patent/JP4264322B2/en not_active Expired - Lifetime
-
2004
- 2004-09-30 CN CN2004800291374A patent/CN1863907B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN1863907A (en) | 2006-11-15 |
JP2005110540A (en) | 2005-04-28 |
CN1863907B (en) | 2011-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
McElwee et al. | Cultured peribulbar dermal sheath cells can induce hair follicle development and contribute to the dermal sheath and dermal papilla | |
KR101077760B1 (en) | Progenitor cells from wharton's jelly of human umbilical cord | |
Yoshida et al. | Birth of piglets derived from in vitro fertilization of pig oocytes matured in vitro | |
JP2006525006A (en) | Cryopreservation method of stem cells derived from human blastocysts using the closed straw vitrification method | |
Silani et al. | Human neuronal cell viability demonstrated in culture after cryopreservation | |
US20100227397A1 (en) | Preparation method of a hair dermal papilla cell preparation, composition and method for regenerating hair follicles, and animal having regenerated hair follicles | |
US20090186004A1 (en) | Method For Preparing An Organ For Transplantation | |
KR20130112872A (en) | Composition for regenerating follicle which contains cd36-expressing connective tissue sheath cells | |
JP4689175B2 (en) | Composition, method for regenerating hair follicle and animal carrying regenerated hair follicle | |
JP4264322B2 (en) | Preparation method of dermal papilla cell preparation | |
Zhang et al. | Combating ovarian aging depends on the use of existing ovarian follicles, not on putative oogonial stem cells | |
CN1968713B (en) | Method of regenerating follicles by inhibiting gene capable of inhibiting follicle formation or activating gene capable of inducing follicle formation | |
JP5164439B2 (en) | Hair papilla cell culture method | |
KR20120126634A (en) | Preservation Method for Tissues | |
WO2023176017A1 (en) | Oocyte maturation promoter and uses thereof | |
Porcellini et al. | Ontogeny of granulocyte‐macrophage progenitor cells in the human fetus | |
JP6582044B2 (en) | Method for producing frozen mesenchymal cells and method for producing therapeutic material for transplantation | |
JP2006028169A (en) | Method for regenerating hair follicle by suppressing gene having hair follicle formation-suppressing ability | |
CA3205553A1 (en) | Methods for optimizing reproductive tissue derived cell yield and viability for clinical applications | |
JP6101066B2 (en) | Preparation method of melanocyte population | |
Kumara et al. | Clinical Application of Adult Stem Cells in Veterinary Science: Advances and Limitations | |
Chiara Guida et al. | IN VITRO MODELS OF MULTIPOTENT ADULT STEM CELLS | |
PL211680B1 (en) | Method for the deriving of MIC-1 mother cell lines from growing antlers of animals belonging to the deer family (Cervidae) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060313 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090203 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090216 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120220 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4264322 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120220 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130220 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130220 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140220 Year of fee payment: 5 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |